Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phenylephrine injection - Dr Reddy's Laboratories

Next Previous
Drug Profile

Phenylephrine injection - Dr Reddy's Laboratories

Alternative Names: Biorphen; ET 202; Phenylephrine hydrochloride - Eton Pharmaceuticals

Latest Information Update: 29 Jun 2022

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Sintetica
  • Developer Eton Pharmaceuticals
  • Class Antihypotensives; Decongestants; Ethanolamines; Mydriatics; Phenethylamines; Skin disorder therapies; Small molecules; Urologics
  • Mechanism of Action Alpha 1 adrenergic receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Hypotension

Most Recent Events

  • 24 Jun 2022 Dr Reddy's Laboratories acquires phenylephrine form Eton Pharmaceuticals
  • 21 Jan 2020 Eton Pharmaceuticals and Xellia Pharmaceuticals enter into a co-promotion agreement to promote phenylephrine injection
  • 02 Dec 2019 Launched for Hypotension in USA (IV)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top